Fueling an Epidemic: Inside the Insys Strategy for Boosting Fentanyl Sales

Publication

Fueling an Epidemic: Inside the Insys Strategy for Boosting Fentanyl Sales

Senate Committee on Homeland Security and Governmental Affairs

Abstract

The Senate Committee on Homeland Security and Governmental Affairs issued a Minority Staff Report on allegations that Insys Therapeutics engaged in a fraudulent compensation scheme that involved bribing physicians to increase sales of Subsys (fentanyl), raising concerns about pharmaceutical practices with potential public health implications.

Date

2018-10-17

Document Type

Senate Minority Staff Report

Document Length

193 pages

Congress

115

Show all metadata

Files

2018-10-17_R-Fueling_an_Epidemic-Inside_the_Insys_Strategy_for_Boosting_Fentanyl_Sales-115C.pdf

Adobe PDF, 21.1 MB

URI

https://hdl.handle.net/20.500.14300/443

Keywords

Staff Reports, Senate, Democrat

PAP Major Code

3: Health

PAP Minor Code

342: Substance, Alcohol and Drug Abuse, Treatment and Education

Cited Hearings

N/A

Collections

Senate Oversight Committee

Fueling an Epidemic: Inside the Insys Strategy for Boosting Fentanyl Sales

Senate Committee on Homeland Security and Governmental Affairs

Citations

Abstract

Date

Document Type

Serial Number

Document Length

Congress

Files

URI

Relation

DOI

Keywords

PAP Major Code

PAP Minor Code

Cited Hearings

Press Releases and Contextual Information

Collections